|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| C12Q 1/68 |
| (11) | Number of the document | 2235535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08859508.7 |
| Date of filing the European patent application | 2008-12-05 | |
| (97) | Date of publication of the European application | 2010-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/013448 |
| Date | 2008-12-05 |
| (87) | Number | WO 2009/075797 |
| Date | 2009-06-18 |
| (30) | Number | Date | Country code |
| 5806 P | 2007-12-07 | US |
| (72) |
SCHAFER, Peter, H., US
BARTLETT, Justin, B., US
ZHANG, Ling-Hua, US
|
| (73) |
CELGENE CORPORATION,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN`S LYMPHOMA |
| BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN`S LYMPHOMA |